Diabetes Mellitus, Type 1NCT02546063
Carbohydrate Estimation Supported by the GoCARB System
A study testing Smartphone App in people with Diabetes Mellitus, Type 1 and Carbohydrates, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.
Trial summary
The standard method for determining the carbohydrate content of a meal in patients with diabetes mellitus is the weighing of individual foods. However, in daily life, the weighing is not practical at all times. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Diabetes Mellitus, Type 1, Carbohydrates
- What is being tested?
- Smartphone App
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteSwitzerland
- Study dates
- Aug 2015to Dec 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Type 1 diabetes
- Minimum age of 18 years old
- Sensor-augmented pump therapy for at least six months
- HbA1c levels within the last 4 months ≤ 8.5%
- Familiar with carbohydrate (CHO) counting (e.g. CHO counting training in the past)
- Normal insulin sensitivity (reflected by a daily insulin requirement of 0.3-1.0 U/kg body weight)
- Able to comprehend German or English
- Written informed consent
Who cannot join
- Relevant diabetic complications
- Hypoglycemia unawareness
- More than one episode of severe hypoglycemia as defined by American Diabetes Association in preceding 12 months
- Pregnancy
- Relevant psychiatric disorder
- Active neoplasia
- Participation in another study
- Other individuals especially in need of protection (according to the guidelines of the Swiss Academy of Medical Sciences)
Trial locations and contacts
1 site in 1 country.
Switzerland1 site
Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital
Bern, 3010
About this study
Official title: Carbohydrate Estimation Supported by the GoCARB System in Individuals With Type 1 Diabetes
The standard method for determining the carbohydrate content of a meal in patients with diabetes mellitus is the weighing of individual foods. However, in daily life, the weighing is not practical at all times. Inaccurate estimation of meal's CHO content, leads to wrong insulin doses and consequently to poor postprandial glucose control. Fact is that even well trained diabetic individuals find it difficult to estimate CHO precisely and that especially meals served on a plate are prone to false estimations underlining an emergent need for novel approaches to CHO estimation.
GoCarb is a computer vision-based system for calculating the carbohydrate content of meals. In a typical scenario, the user places a credit card-sized reference object next to the meal and acquires two images using his/her smartphone. A series of computer vision modules follows: the plate is detected and the different food items on the plate are automatically segmented and recognized, while their 3D shape is reconstructed. On the basis of the shape, the segmentation results and the reference card, the volume of each item is then estimated. The CHO content is calculated by combining the food types with its volumes, and by using the USDA nutritional database. Finally, the results are displayed to the user.
Read more
A preclinical study using the GoCarb system indicates that the system is able to estimate the meal's CHO content with higher accuracy than individuals with T1D. Furthermore, the feedback gathered by the participants showed that the system is easy to use even for non-smartphone users.
The aim of this randomized, cross-over pilot study is to investigate the benefits of an automated determination of the carbohydrate content of meals on glycemic control in subjects with type 1 diabetes mellitus with sensor-augmented insulin pump therapy.
Read the detailed description
Background
For individuals with type 1 diabetes (T1D) the current gold standard to evaluate the carbohydrate (CHO) amount of a meal is by carefully weighing its different components and calculating the CHO content using reference nutritional tables. The resulting CHO amount is then used to define the insulin dose needed to avoid an abnormal postprandial glucose profile. Since this is a cumbersome procedure in real life, diabetic individuals often estimate the CHO amount based on their personal experience. Especially for food served on a plate CHO estimates are often significantly over or underestimated leading to high variation in postprandial blood glucose. Besides the immediate risk of hypoglycaemia, there is emerging evidence that suboptimal control of postprandial glucose is affiliated with increased risk for long-term complications (e.g. diabetic micro- and macro-vascular diseases).
The effect of CHO counting in T1D control has been increasingly recognized and investigated. A meta-analysis including five studies on individuals with T1D has shown, that improved CHO counting accuracy reduces the HbA1c significantly (0.64% reduction in HbA1c compared to a control group). Teaching adult individuals with T1D to count CHO reduces HbA1c significantly and also leads to an improvement in quality of life. Similar findings are reported in children, in whom higher CHO counting accuracy is associated with a lower HbA1c. Even a short educational intervention of 4 weeks can still result in a significant and sustained effect on HbA1c reduction 9 months after without having an increase in hypoglycaemia. Lower CHO counting accuracy is a significant predictor of prolonged time in hyperglycaemic state. In one study with adults only 31% of the participants estimated the CHO content with an error of less than 20 grams per day and accurate CHO estimation were correlated with the lowest HbA1c values. In line with these findings another study has shown that individuals on intensive insulin therapy count CHO content of meals with an average error in the order of 16 grams or 21%. In general there is overestimation of small meals and a substantial underestimation of large meals. While breakfast (+8.5%) and snacks (-5%) were estimated fairly accurately, lunch (-28%) and dinner (-23%) are more prone to errors leading to an underestimation in the order of 30 grams. In children, an inaccuracy of ±10grams does not deteriorate the postprandial glycaemic control, whereas a ±20 grams variation significantly impacts the postprandial glycaemia.
The debate how to optimally estimate CHO intake is on-going and controversial. Fact is that even well trained diabetic individuals find it difficult to estimate CHO precisely and that especially meals served on a plate are prone to false estimations underlining an emergent need for novel approaches to CHO estimation. The investigators hypothesize that computer vision supported CHO estimation can have a beneficial impact on postprandial glucose control, ultimately leading to reduced episodes of hypoglycaemia and reduction in long term complications.
The recent advances in smartphone technologies and computer vision permitted the development of applications for the automatic dietary assessment through meal image analysis. The applications are using either a number of images or a short video of the upcoming meal, as captured by the user's smartphone. Although several systems have been proposed in the past decade, none of them is designed for individuals with diabetes, while they rely on strong assumptions, which often do not hold in real life, or require too much user input. The GoCARB system provides CHO estimations to individuals with T1D, by using only two meal images. The current version GoCARB has been designed to deal with
- elliptical plates with a flat base;
- single-dish images;
- fully visible food items. The system works without assumptions on the food shape, while it supports the following food classes: Pasta, green salad, meat, breaded food, beans, carrots, mashed potato, rice, potatoes, bread, cheese, egg, couscous, mushrooms and spätzli.
Objective
The purpose of this study is to investigate the effect of GoCARB-supported CHO estimation in the postprandial glucose control of individuals with T1D on sensor augmented insulin pump therapy.
In a typical scenario, the user places a credit card-sized reference object next to the meal and acquires two images using her/his smartphone. A graphical user interface guides the user in choosing the optimal angles for image acquisition based on the smartphone's built-in sensors. The images are then transmitted to a dedicated server via Wi-Fi or the mobile network. Then, the following computer vision algorithms are activated: the plate is detected and the different food items on the plate are automatically segmented and recognized, while their 3D shape is reconstructed. On the basis of the shape, the segmentation results and the reference card, the volume and CHO content of each item is then calculated by combining the food types with its volumes. Finally, the results are displayed to the user.
Methods
This study's overall objective is to perform a prospective randomized controlled clinical pilot study comparing postprandial glucose control assisted by the GoCARB system against the usual care approach by the participants. Scope of the study will be to investigate whether the postprandial glucose profile is improved by using the GoCARB prototype for CHO estimation. Postprandial glycaemia is evaluated using continuous glucose monitoring.
- Conditions
- Diabetes Mellitus, Type 1, Carbohydrates
- Being tested
- Smartphone App
- Medical subject headings
- Diabetes Mellitus, Type 1
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Smartphone AppOther
The GoCARB system is a smartphone application designed to support type 1 diabetic patients with carbohydrate counting by providing automatic, accurate and near real-time CHO estimation for non-packed foods.
| Study group | Role | What they receive |
|---|---|---|
| GoCARB app | Other | Smartphone app Receives: Other: Smartphone App |
| Conventional carbohydrate estimating methods | No intervention | Individual usual carbohydrate estimation methods (weighing, experience, carbohydrate exchange tables etc.). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Average of the postprandial area under the glucose curve (AUC) measured over three hours after each meal's start using Continuous Glucose Monitoring
Measured: 14 days
Secondary outcomes (4)
Composite of insulin-related parameters
Calculated from daily bolus, basal and correction insulin
Measured: 14 days
Glucose-related parameters
Postprandial glucose levels within, below and above target
Measured: 14 days
Daily nutritional behavior in individuals with T1D
Measured in kcal and documented by photographs
Measured: 14 days
User satisfaction
Composite measured by questionnaire: Participants will be invited to complete three questionnaires: i) a carbohydrate counting specific questionnaire including questions concerning educational level and former training of carbohydrate counting, and ii) a questionnaire related to GoCARB's features.
Measured: 14 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Sep 2015 (estimated)
- Study startAug 2015
- Primary completionDec 2015
- Study completionDec 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Diabetes Mellitus, Type 1Studies of the same condition, open and under way.
- More trials run by Insel Gruppe AG, University Hospital BernThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Christoph Stettler, Principal investigator, Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University HospitalStavroula Mougiakakou, Principal investigator, Diabetes Technology Research Group, ARTORG Center for Biomedical Engineering Research, University of BernMarkus Laimer, Principal investigator, Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02546063
- Sponsor's protocol ID
- 100/15
- Status last verified
- Aug 2016
- First submitted
- 4 Sep 2015
- Last updated
- 10 Aug 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Anthimopoulos MM, Gianola L, Scarnato L, Diem P, Mougiakakou SG. A food recognition system for diabetic patients based on an optimized bag-of-features model. IEEE J Biomed Health Inform. 2014 Jul;18(4):1261-71. doi: 10.1109/JBHI.2014.2308928.
PubMed 25014934Agianniotis A, Anthimopoulos M, Daskalaki E, Drapela A, Stettler C, Diem P, Mougiakakou S. GoCARB in the Context of an Artificial Pancreas. J Diabetes Sci Technol. 2015 May;9(3):549-55. doi: 10.1177/1932296815583333. Epub 2015 Apr 21.
PubMed 25904142Anthimopoulos M, Dehais J, Shevchik S, Ransford BH, Duke D, Diem P, Mougiakakou S. Computer vision-based carbohydrate estimation for type 1 patients with diabetes using smartphones. J Diabetes Sci Technol. 2015 May;9(3):507-15. doi: 10.1177/1932296815580159. Epub 2015 Apr 16.
PubMed 25883163Bally L, Dehais J, Nakas CT, Anthimopoulos M, Laimer M, Rhyner D, Rosenberg G, Zueger T, Diem P, Mougiakakou S, Stettler C. Carbohydrate Estimation Supported by the GoCARB System in Individuals With Type 1 Diabetes: A Randomized Prospective Pilot Study. Diabetes Care. 2017 Feb;40(2):e6-e7. doi: 10.2337/dc16-2173. Epub 2016 Nov 29. No abstract available.
PubMed 27899490
Study at a glance
From the registry record, last updated by the sponsor on 10 Aug 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Carbohydrate Estimation Supported by the GoCARB System in Individuals With Type 1 Diabetes
- ClinicalTrials.gov ID
- NCT02546063
- Acronym / sponsor ID
- 100/15
- Conditions
- Diabetes Mellitus, Type 1, Carbohydrates
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Insel Gruppe AG, University Hospital BernUniversity, hospital or other
- Study start
- Aug 2015
- Primary completion
- Dec 2015 (actual)
- Study completion
- Dec 2015 (actual)
- First posted
- 10 Sep 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The standard method for determining the carbohydrate content of a meal in patients with diabetes mellitus is the weighing of individual foods. However, in daily life, the weighing is not practical at all times. Inaccurate estimation of meal's CHO content, leads to wrong insulin doses and consequently to poor postprandial glucose control. Fact is that even well trained diabetic individuals find it difficult to estimate CHO precisely and that especially meals served on a plate are prone to false estimations underlining an emergent need for novel approaches to CHO estimation.
GoCarb is a computer vision-based system for calculating the carbohydrate content of meals. In a typical scenario, the user places a credit card-sized reference object next to the meal and acquires two images using his/her smartphone. A series of computer vision modules follows: the plate is detected and the different food items on the plate are automatically segmented and recognized, while their 3D shape is reconstructed. On the basis of the shape, the segmentation results and the reference card, the volume of each item is then estimated. The CHO content is calculated by combining the food types with its volumes, and by using the USDA nutritional database. Finally, the results are displayed to the user.
A preclinical study using the GoCarb system indicates that the system is able to estimate the meal's CHO content with higher accuracy than individuals with T1D. Furthermore, the feedback gathered by the participants showed that the system is easy to use even for non-smartphone users.
The aim of this randomized, cross-over pilot study is to investigate the benefits of an automated determination of the carbohydrate content of meals on glycemic control in subjects with type 1 diabetes mellitus with sensor-augmented insulin pump therapy.
Detailed description
Background
For individuals with type 1 diabetes (T1D) the current gold standard to evaluate the carbohydrate (CHO) amount of a meal is by carefully weighing its different components and calculating the CHO content using reference nutritional tables. The resulting CHO amount is then used to define the insulin dose needed to avoid an abnormal postprandial glucose profile. Since this is a cumbersome procedure in real life, diabetic individuals often estimate the CHO amount based on their personal experience. Especially for food served on a plate CHO estimates are often significantly over or underestimated leading to high variation in postprandial blood glucose. Besides the immediate risk of hypoglycaemia, there is emerging evidence that suboptimal control of postprandial glucose is affiliated with increased risk for long-term complications (e.g. diabetic micro- and macro-vascular diseases).
The effect of CHO counting in T1D control has been increasingly recognized and investigated. A meta-analysis including five studies on individuals with T1D has shown, that improved CHO counting accuracy reduces the HbA1c significantly (0.64% reduction in HbA1c compared to a control group). Teaching adult individuals with T1D to count CHO reduces HbA1c significantly and also leads to an improvement in quality of life. Similar findings are reported in children, in whom higher CHO counting accuracy is associated with a lower HbA1c. Even a short educational intervention of 4 weeks can still result in a significant and sustained effect on HbA1c reduction 9 months after without having an increase in hypoglycaemia. Lower CHO counting accuracy is a significant predictor of prolonged time in hyperglycaemic state. In one study with adults only 31% of the participants estimated the CHO content with an error of less than 20 grams per day and accurate CHO estimation were correlated with the lowest HbA1c values. In line with these findings another study has shown that individuals on intensive insulin therapy count CHO content of meals with an average error in the order of 16 grams or 21%. In general there is overestimation of small meals and a substantial underestimation of large meals. While breakfast (+8.5%) and snacks (-5%) were estimated fairly accurately, lunch (-28%) and dinner (-23%) are more prone to errors leading to an underestimation in the order of 30 grams. In children, an inaccuracy of ±10grams does not deteriorate the postprandial glycaemic control, whereas a ±20 grams variation significantly impacts the postprandial glycaemia.
The debate how to optimally estimate CHO intake is on-going and controversial. Fact is that even well trained diabetic individuals find it difficult to estimate CHO precisely and that especially meals served on a plate are prone to false estimations underlining an emergent need for novel approaches to CHO estimation. The investigators hypothesize that computer vision supported CHO estimation can have a beneficial impact on postprandial glucose control, ultimately leading to reduced episodes of hypoglycaemia and reduction in long term complications.
The recent advances in smartphone technologies and computer vision permitted the development of applications for the automatic dietary assessment through meal image analysis. The applications are using either a number of images or a short video of the upcoming meal, as captured by the user's smartphone. Although several systems have been proposed in the past decade, none of them is designed for individuals with diabetes, while they rely on strong assumptions, which often do not hold in real life, or require too much user input. The GoCARB system provides CHO estimations to individuals with T1D, by using only two meal images. The current version GoCARB has been designed to deal with
- elliptical plates with a flat base;
- single-dish images;
- fully visible food items. The system works without assumptions on the food shape, while it supports the following food classes: Pasta, green salad, meat, breaded food, beans, carrots, mashed potato, rice, potatoes, bread, cheese, egg, couscous, mushrooms and spätzli.
Objective
The purpose of this study is to investigate the effect of GoCARB-supported CHO estimation in the postprandial glucose control of individuals with T1D on sensor augmented insulin pump therapy.
In a typical scenario, the user places a credit card-sized reference object next to the meal and acquires two images using her/his smartphone. A graphical user interface guides the user in choosing the optimal angles for image acquisition based on the smartphone's built-in sensors. The images are then transmitted to a dedicated server via Wi-Fi or the mobile network. Then, the following computer vision algorithms are activated: the plate is detected and the different food items on the plate are automatically segmented and recognized, while their 3D shape is reconstructed. On the basis of the shape, the segmentation results and the reference card, the volume and CHO content of each item is then calculated by combining the food types with its volumes. Finally, the results are displayed to the user.
Methods
This study's overall objective is to perform a prospective randomized controlled clinical pilot study comparing postprandial glucose control assisted by the GoCARB system against the usual care approach by the participants. Scope of the study will be to investigate whether the postprandial glucose profile is improved by using the GoCARB prototype for CHO estimation. Postprandial glycaemia is evaluated using continuous glucose monitoring.
Study design
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| GoCARB app | Other | Other: Smartphone AppSmartphone app |
| Conventional carbohydrate estimating methods | No intervention | –Individual usual carbohydrate estimation methods (weighing, experience, carbohydrate exchange tables etc.). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Type 1 diabetes
- Minimum age of 18 years old
- Sensor-augmented pump therapy for at least six months
- HbA1c levels within the last 4 months ≤ 8.5%
- Familiar with carbohydrate (CHO) counting (e.g. CHO counting training in the past)
Key exclusion criteria (8 listed)
- Relevant diabetic complications
- Hypoglycemia unawareness
- More than one episode of severe hypoglycemia as defined by American Diabetes Association in preceding 12 months
- Pregnancy
- Relevant psychiatric disorder
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Smartphone AppThe GoCARB system is a smartphone application designed to support type 1 diabetic patients with carbohydrate counting by providing automatic, accurate and near real-time CHO estimation for non-packed foods. | Other | GoCARB app |
Primary outcome
Average of the postprandial area under the glucose curve (AUC) measured over three hours after each meal's start using Continuous Glucose Monitoring
Time frame: 14 days
4 secondary outcomes
Composite of insulin-related parameters
Time frame: 14 days
Glucose-related parameters
Time frame: 14 days
Daily nutritional behavior in individuals with T1D
Time frame: 14 days
User satisfaction
Time frame: 14 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Aug 2016.
- Background: PubMed 25014934Anthimopoulos MM, Gianola L, Scarnato L, Diem P, Mougiakakou SG. A food recognition system for diabetic patients based on an optimized bag-of-features model. IEEE J Biomed Health Inform. 2014 Jul;18(4):1261-71. doi: 10.1109/JBHI.2014.2308928.
- Results publication: PubMed 25904142Agianniotis A, Anthimopoulos M, Daskalaki E, Drapela A, Stettler C, Diem P, Mougiakakou S. GoCARB in the Context of an Artificial Pancreas. J Diabetes Sci Technol. 2015 May;9(3):549-55. doi: 10.1177/1932296815583333. Epub 2015 Apr 21.
- Results publication: PubMed 25883163Anthimopoulos M, Dehais J, Shevchik S, Ransford BH, Duke D, Diem P, Mougiakakou S. Computer vision-based carbohydrate estimation for type 1 patients with diabetes using smartphones. J Diabetes Sci Technol. 2015 May;9(3):507-15. doi: 10.1177/1932296815580159. Epub 2015 Apr 16.
- Derived from this study: PubMed 27899490Bally L, Dehais J, Nakas CT, Anthimopoulos M, Laimer M, Rhyner D, Rosenberg G, Zueger T, Diem P, Mougiakakou S, Stettler C. Carbohydrate Estimation Supported by the GoCARB System in Individuals With Type 1 Diabetes: A Randomized Prospective Pilot Study. Diabetes Care. 2017 Feb;40(2):e6-e7. doi: 10.2337/dc16-2173. Epub 2016 Nov 29. No abstract available.
- Individual participant dataSharing planned: No
Related trials for Diabetes Mellitus, Type 1
Recruiting
C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
Type 1 Diabetes
RecruitingPhase 3
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Diabetes Mellitus, Type 1
Not yet recruitingPhase 3
CKM For Safe Use of SGLT2i in Type 1 Diabetes
Type 1 Diabetes (T1D)
Active, not recruitingPhase 1
Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen
Diabetes Mellitus
RecruitingPhase 3
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Diabetes Mellitus, Type 1
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christoph Stettler principal investigator
Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital
Stavroula Mougiakakou principal investigator
Diabetes Technology Research Group, ARTORG Center for Biomedical Engineering Research, University of Bern
Markus Laimer principal investigator
Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Smartphone App in people with Diabetes Mellitus, Type 1 and Carbohydrates, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Average of the postprandial area under the glucose curve (AUC) measured over three hours after each meal's start using Continuous Glucose Monitoring (time frame: 14 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02546063, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2016.